Compound sixty has an exceptionally significant affinity to MDM2 (Ki Now, all around eleven million people today are living that has a tumour that contains an inactivating mutation of TP53 (the human gene that encodes p53) and A different 11 million have tumours wherein the p53 pathway is partially abrogated in the inactivation of other signalling